BackGlobal Blood Therapeutics Overview

Global Blood Therapeutics Inventory

Global Blood Therapeutics's inventory is $66M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$65.82M
37.14% YoYΔ $17.82M vs prior year quarter

Peer average / median

Loading

Global Blood Therapeutics Inventory History

Loading

Global Blood Therapeutics vs. peers: Inventory Comparison

Loading

Global Blood Therapeutics Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Global Blood Therapeutics (GBT) FAQ

As of the most recent data (June 2022), GBT shows a inventory of $66M. That compares with $48M in the prior-year period — up 37.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GBT's inventory is now $66M (was $48M) — a 37.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Global Blood Therapeutics is outperforming or lagging.

Tracking GBT's inventory over time shows whether Global Blood Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $66M That compares with $48M in the prior-year period — up 37.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Global Blood Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $66M) with ownership activity and broader fundamentals.

Global Blood Therapeutics's inventory is $66M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.